Estimating the size of the monkeypox virus outbreak in Nigeria and implications for global control

• Published in: Journal of travel medicine 2022-12, Vol.29 (8)
• Main Authors: Marwah, Anindita, Ogoina, Dimie, Au, Natalie H, Gibb, Nick P, Portillo, Mariana Torres, Thomas-Bachli, Andrea, Demarsh, P Alex, Bogoch, Isaac I, Khan, Kamran
• Format: Article
• Language: English
• Subjects: Disease Outbreaks; Epidemics; Humans; Monkeypox virus; Mpox; Mpox (monkeypox) - epidemiology; Nigeria - epidemiology; Outbreaks; Public Health; Tourism; Travellers; Viruses
• ISSN: 1195-1982; 1708-8305
• DOI: 10.1093/jtm/taac149

Abstract Background A multi-country outbreak caused by monkeypox virus (MPXV) has been unfolding across endemic and non-endemic countries since May 2022. Throughout April and May 2022, Nigeria reported 31 MPXV cases, of which 11 were confirmed via testing. In May 2022, three internationally exported cases of MPXV, presumed to have originated in Nigeria, were reported, suggesting that a larger than reported outbreak might be occurring in the country. Methods We used previously established methods to estimate the true size of the MPXV outbreak in Nigeria. We estimated the incidence rate of exported MPXV cases among all outbound international air travellers from Nigeria during the time period of April and May 2022, using forecasted air traveller volumes. We then applied this incidence rate to the entire population of Nigeria during April and May 2022 assuming that the rate of infection was the same in Nigeria for both travellers and the resident population. Information on the subset of population that were considered to be travellers was obtained from the United Nations World Tourism Organization (UNWTO). Results We estimated that there were approximately 4000 (N = 4013; 95% CI: 828–11 728) active cases of MPXV in Nigeria in April and May 2022. This is approximately 360-fold greater than the confirmed number and approximately 130-fold greater than the reported number of cases in Nigeria. Conclusion Our findings suggest that a larger outbreak than is appreciated may be ongoing in Nigeria. The observed international spread of MPXV offers important insights into the scale of the epidemic at its origin, where clinical detection and disease surveillance may be limited. These findings highlight the need to expand and support clinical, laboratory, and public health capacity to enable earlier detection of epidemics of international significance.